Hazards
of "Modern" Medicine
By Barry Charles, M.D.
These hazards are avoided by Maharishi's
Vedic Approach to Health
Harmful
effects, which can be serious and even lethal,
are associated with every facet of modern
medicine...
Injury from medical treatment in the U.S.
accounts for more deaths than all other
accidents combined. |
|
|
Iatrogenic illness--disease produced as a result
of medical treatment--is now recognized as a health
hazard of global proportions. MEDLINE (the
computerized medical research database of the United
States National Library of Medicine) includes over
7,000 articles, reports, and scientific research
papers since 1966 that show a substantial number of
patients suffer treatment-caused disorders and adverse
drug reactions. These harmful effects, which can be
serious and even lethal, are associated with every
facet of modern medicine including drugs, other
medical therapies, diagnostic procedures, and surgery.
Detrimental effects have become so extensive as to
prompt the use of the term "iatroepidemic2".
Reporting in the Journal of the American Medical
Association, Dr. Lucien Leape of Harvard School of
Public Health, has calculated that "180,000
people die in the U.S. each year partly as a result of
iatrogenic injury, the equivalent of three jumbo-jet
crashes every two days3".
In another issue, the Journal of the American Medical
Association points out that injury from medical
treatment in the U.S. "dwarfs the annual
automobile accident mortality of 45,000 and accounts
for more deaths than all other accidents combined 4".
|
Medication-
caused disorders costs are nearly twice that
spent on diabetes treatment and near the
amount for cardiovascular disease.
Fifteen per cent of hospital days are devoted
to the treatment of drug side effects.
Every medication, including those that are
sold over the counter without a prescription,
has an associated side effect.
|
|
|
Medication-caused disorders produce a substantial
economic drain. For example, the Archives of Internal
Medicine reported a cost to the U.S. economy of $76
billion in 1995. This amount is nearly twice that
spent on diabetes treatment and near the amount for
cardiovascular disease 5.
Iatrogenic disease can be due to many factors. These
include: errors in prescribing or administering drugs
and other treatments; accidents; inappropriate use of
diagnostic or therapeutic measures; and the intrinsic
potential for harm and side effects associated with
medications, surgery, and other procedures.
The hospital environment is especially conducive to
medical hazards. tudies including those conducted at
Harvard Medical School show that as many as 36 per
cent of patients admitted to hospitals suffered
iatrogenic injury with up to 25 per cent of those
being serious or fatal. Up to half of these injuries
were related to the use of medication 6.
The results of an analysis of cardiac arrests at a
teaching hospital found that 64 per cent were
preventable. Inappropriate use of drugs was the
leading cause7.
In addition to treatment-caused disorders,
hospitals foster life-threatening nosocomial
infections involving rare or drug-resistant
microorganisms, which are o ften difficult to treat.
Fifteen per cent of hospital days are devoted to
the treatment of drug side effects8.
Every medication, including those that are sold over
the counter without a prescription, has an associated
side effect. Commonly used drugs have been found to
affect every system. Frequent reactions include skin
rashes, nausea, headaches, dizziness, lethargy,
diarrhea, and gastric bleeding in a significant number
of people. More severe reactions that can be fatal or
severely debilitating include deafness, depression,
abnormal heart rhythms, angina, bronchospasm,
electrolyte disturbances, immune system dysfunction,
serious blood disorders such as aplastic anemia, liver
or kidney toxicity, Stevens-Johnson syndrome, or
anaphylactic shock. These occur in a statistically
significant proportion of the population. Despite what
is known about adverse drug effects, Dr. David
Kessler, Chief of the U.S. Food and Drug
Administration, believes that "only one per cent
of all serious drug reactions are reported 9".
|
The problem escalates to public health
proportions when large numbers receive a
treatment and experience its attendant side
effect.
Many drugs have side effects serious enough to
cause a secondary disease warranting its own
intensive therapy. |
|
|
The problem escalates to public health proportions
when large numbers receive a treatment and experience
its attendant side effect. The New England Journal of
Medicine makes this point in discussing the link
between breast cancer and menopausal hormone
replacement therapy: "because of the high
incidence of breast cancer even a slight increase in
risk will yield a substantial increase in the number
of cancers10".
The scale of use causes drugs which are considered
safe to end up producing significant damage. In this
regard, the widely used non-steroidal
anti-inflammatory drugs cause over 3,300 deaths per
year and 41,000 hospitalizations.
Many drugs have side effects serious enough to
cause a secondary disease warranting its own intensive
therapy. An example is Parkinsonism caused by the
neurological side effects of anti-depressants or
anti-psychotic medication. A Harvard Medical School
study showed that drugs were the real cause of the
original symptoms in 37 per cent of elderly patients
who were treated for Parkinson's disease. L-dopa, the
medication used in treating these patients has its own
severe side effects, that often require the use of
additional drugs to control11.
Other examples of new diseases caused by medications
include collagen vascular disease produced by blood
pressure medications, and Cushing's syndrome produced
by prolonged cortico-steroid use. The New England
Journal of Medicine has published several studies
linking cancer chemotherapy to the later appearance of
new malignancies 12.
Many drugs are classified as teratogens and cause
birth defects when taken during pregnancy. Others can
cause diseases in offspring in later life.
Unfortunately, these effects may not become
apparent until many thousands of women have taken a
drug which had been enthusiastically introduced and
promoted, the classic example being the tragic
epidemic of birth defects in Europe due to
thalidomide, or cancer in the children of mothers who
took diethylstilbestrol.
Overuse of antibiotics has produced resistant
strains of formerly susceptible micro-organisms.
Serious concern has been voiced about the potential
for epidemics which cannot be effectively contained
due to drug resistance. An example of this is the
emergence of tuberculosis that is resistant to
presently available drugs.
|
A U.S.
Congress Subcommittee found that in one year
unnecessary operations were responsible for
more than 12,000 deaths,
Dependency on high technology is a often a
source of injury.
Only 15 Percent of medical therapies were
found to be reliable, or scientifically based. |
|
|
Studies also show substantial inappropriate and
overuse of surgery, and continued use of outmoded
operations. A U.S. Congress Subcommittee on Oversight
and Investigations into Unnecessary Surgery found that
in one year, there were approximately two million
unnecessary operations, responsible for more than
12,000 deaths, with an approximate cost wastage of $10
billion 13.
Dependency on high technology both in diagnosis and
treatment has been shown to be a source of injury with
machine failure or misapplication of technology. For
example, 36 per cent of iatrogenic problems in
intensive care units were associated with equipment
malfunction14.
In addition, medical care is often based on much
less scientific evidence than assumed and undergoes
radical reversals. The editor of the British Medical
Journal revealed that only 15 per cent of all medical
therapies have a scientific basis or have been
demonstrated to be effective15.
Yet patients remain vulnerable. An example is the
formerly common use of irradiation for enlargement of
the thymus in infancy, a condition now recognized to
be normal. This treatment has recently been shown to
cause cancer in later life in those who received it16
|
Pharmaceutical
companies push physicians to prescribe new
drugs and don't reveal scientific information
that oppose the use of that drug.
Developing countries have had special problems
with irrational drug marketing by
multinational and indigenous pharmaceutical
companies. |
|
|
Pharmaceutical marketing also puts great pressure
on physicians to use new products. The medical journal
Hospital Practice pointed out that pharmaceutical
company competition "leads to very aggressive
promotion and inundation of the physician with data
supporting the use of each new drug". Such
marketing may dilute opposing scientific information
that is not as well publicized. Ultimately drugs may
be withdrawn, but only after substantial harm has been
done. For example, benoxaprofen, a non-steroidal
anti-inflammatory agent (NSAID) was introduced and
heavily marketed in 1982, but then withdrawn after
cases of fatal liver toxicity were reported in Great
Britain. Zomepirac sodium was also "aggressively
marketed as a safe analgesic", but withdrawn
after a year and numerous reports of fatal anaphylaxis17.
The cardiac drugs flecainide and encainide, heavily
promoted to control abnormal heart rhythms, were then
withdrawn years later after scientific studies showed
they caused fatal arrythmias and that those treated
with them were two-and-one-half times as likely to die
as were those taking a placebo.
Developing countries, which have less stringent
controls and means of surveillance, have had special
problems with irrational drug marketing by
multinational and indigenous pharmaceutical companies
that have been carefully documented. These practices
have been reviewed in the Journal of Clinical
Epidemiology by several authors including Dr. Philip
Lee, the United States Assistant Secretary of Health.
According to Dr. Lee and his colleagues,
"unjustified claims of efficacy or safety
continue to proliferate 18".
In addition to side effects, the high cost of
pharmaceuticals are a significant hazard to the
economy of developing countries.
|
The wealth
of data has made clear that fundamental
deficiencies exist in the current medical
approach and that new knowledge is urgently
needed. |
|
|
Physicians and patients have come to accept medical
hazards as a necessary price to pay for modern
diagnosis and therapy even though they may be
seriously debilitating or lethal. The same is true
with medical errors. Studies have shown errors to be
so pervasive that mistakes are considered to be an
inevitable part of the medical system, giving rise to
the term "necessary fallibility 19".
The deplorable acceptance of disease or medical error
as a consequence of treatment reflects a deviation
from the most primary principle of medical ethics--primum
non nocere--above all do no harm. The wealth of data
documenting the serious nature and extent of the
hazards associated with modern medicine has made clear
that fundamental deficiencies exist in the current
medical approach and that new knowledge is urgently
needed to effectively address this problem.
References
1. USA Today. September 13, 1995.
2. Review of Respiratory Diseases. 1987; 135:
1152-1156.
3. Journal of the American Medical Association. 1994;
272: 1851-1857.
4. Journal of the American Medical Association. 1995;
274: 29-34.
5. Archives of Internal Medicine. 1995; 155:
1949-1956.
6. Annals of Internal Medicine. 1964; 60: 100-110. New
England Journal of Medicine. 1981; 304: 638-642. New
England Journal of Medicine. 1991; 324: 370-376.
7. Journal of the American Medical Association. 1991;
265: 2815-2820.
8. Harrison's Principles of Internal Medicine. 1994.
9. US News and World Report. January 9, 1995: 49-54.
10. New England Journal of Medicine. 1994; 330:
1062-1071.
11. American Journal of Medicine. 1995; 99: 48-54.
12. New England Journal of Medicine. 1990; 322: 1-6
13. USA Today. October 31, 1983.
14. Nursing Clinics of North America. 1993; 28:
459-473.
15. British Medical Journal. 1991; 303: 798-799.
16. New England Journal of Medicine. 1989; 321:
1281-1284.
17. Hospital Practice. 1989; January 30: 89-94.
18. Journal of Clinical Epidemiology. 1991; 44:
49S-55S.
19. Journal of the American Medical Association. 1989;
261: 1610-1617.
|
© 2000 by Maharishi Vedic University, The
Netherlands
in collaboration with Maharishi Ayurveda Foundation, USA. All
rights reserved.
|
|